Comparison of the retinitis pigmentosa mutations in rhodopsin with a functional map of the C5a receptor

Vision Research

Volumn 46, Issue 27, 2006, Pages 4519-4531

  Hagemann, Ian S ^a   Nikiforovich, Gregory V ^b   Baranski, Thomas J ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

C5a Receptor; Congenital disease; G protein coupled receptor; Retinitis pigmentosa; Rhodopsin; Vision loss

Indexed keywords

COMPLEMENT COMPONENT C5A RECEPTOR; RHODOPSIN;

ARTICLE; CALCULATION; COMPARATIVE STUDY; CORRELATION ANALYSIS; ENERGY; GENE MAPPING; GENETIC ANALYSIS; MUTATION; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; RETINITIS PIGMENTOSA; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; CATTLE; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NIGHT BLINDNESS; PHOTOTRANSDUCTION; PROTEIN STRUCTURE, QUATERNARY; RECEPTOR, ANAPHYLATOXIN C5A; RETINITIS PIGMENTOSA; RHODOPSIN; SEQUENCE ALIGNMENT; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33750606225     PISSN: 00426989     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.visres.2006.07.010     Document Type: Article

References (87)

1. Allegretti M., Moriconi A., Beccari A.R., Di Bitondo R., Bizzarri C., Bertini R., et al. Targeting C5a: recent advances in drug discovery. Current Medicinal Chemistry 12 2 (2005) 217-236
2. Altenbach C., Yang K., Farrens D.L., Farahbakhsh Z.T., Khorana H.G., and Hubbell W.L. Structural features and light-dependent changes in the cytoplasmic interhelical E-F loop region of rhodopsin: a site-directed spin-labeling study. Biochemistry 35 38 (1996) 12470-12478
3. Balasubramanian S., Teissere J.A., Raju D.V., and Hall R.A. Hetero-oligomerization between GABA-A and GABA-B receptors regulates GABAB receptor trafficking. The Journal of Biological Chemistry 279 18 (2004) 18840-18850
4. Baldwin J.M., Schertler G.F., and Unger V.M. An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. Journal of Molecular Biology 272 1 (1997) 144-164
5. Baranski T.J., Herzmark P., Lichtarge O., Gerber B.O., Trueheart J., Meng E.C., et al. C5a receptor activation. Genetic identification of critical residues in four transmembrane helices. The Journal of Biological Chemistry 274 22 (1999) 15757-15765
6. Boesze-Battaglia K., and Schimmel R. Cell membrane lipid composition and distribution: implications for cell function and lessons learned from photoreceptors and platelets. The Journal of Experimental Biology 200 Pt 23 (1997) 2927-2936
7. Bosch L., Ramon E., Del Valle L.J., and Garriga P. Structural and functional role of helices I and II in rhodopsin. A novel interplay evidenced by mutations at Gly-51 and Gly-89 in the transmembrane domain. The Journal of Biological Chemistry 278 22 (2003) 20203-20209
8. Calvert P.D., Govardovskii V.I., Krasnoperova N., Anderson R.E., Lem J., and Makino C.L. Membrane protein diffusion sets the speed of rod phototransduction. Nature 411 6833 (2001) 90-94
9. Cohen G.B., Oprian D.D., and Robinson P.R. Mechanism of activation and inactivation of opsin: role of Glu113 and Lys296. Biochemistry 31 50 (1992) 12592-12601
10. Cook J.V., Faccenda E., Anderson L., Couper G.G., Eidne K.A., and Taylor P.L. Effects of Asn87 and Asp318 mutations on ligand binding and signal transduction in the rat GnRH receptor. Journal of Endocrinology 139 3 (1993) R1-R4
11. Donnelly D., Maudsley S., Gent J.P., Moser R.N., Hurrell C.R., and Findlay J.B. Conserved polar residues in the transmembrane domain of the human tachykinin NK2 receptor: functional roles and structural implications. The Biochemical Journal 339 Pt 1 (1999) 55-61
12. Dryja T.P., Berson E.L., Rao V.R., and Oprian D.D. Heterozygous missense mutation in the rhodopsin gene as a cause of congenital stationary night blindness. Nature Genetics 4 3 (1993) 280-283
13. Dryja T.P., Finn J.T., Peng Y.W., McGee T.L., Berson E.L., and Yau K.W. Mutations in the gene encoding the alpha subunit of the rod cGMP-gated channel in autosomal recessive retinitis pigmentosa. Proceedings of the National Academy of Sciences of the United States of America 92 22 (1995) 10177-10181
14. Dryja T.P., McGee T.L., Hahn L.B., Cowley G.S., Olsson J.E., Reichel E., et al. Mutations within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa. The New England Journal of Medicine 323 19 (1990) 1302-1307
15. Dryja T.P., McGee T.L., Reichel E., Hahn L.B., Cowley G.S., Yandell D.W., et al. A point mutation of the rhodopsin gene in one form of retinitis pigmentosa. Nature 343 6256 (1990) 364-366
16. Dunfield L., Burgess A., and Scheraga H. Energy parameters in polypeptides. 8. Empirical potential energy algorithm for the conformational analysis of large molecules. Journal of Physical Chemistry 82 (1978) 2609-2616
17. Dunham T.D., and Farrens D.L. Conformational changes in rhodopsin. Movement of helix f detected by site-specific chemical labeling and fluorescence spectroscopy. The Journal of Biological Chemistry 274 3 (1999) 1683-1690
18. Farrar G.J., Kenna P.F., and Humphries P. On the genetics of retinitis pigmentosa and on mutation-independent approaches to therapeutic intervention. EMBO Journal 21 5 (2002) 857-864
19. Farrens D.L., Altenbach C., Yang K., Hubbell W.L., and Khorana H.G. Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science 274 5288 (1996) 768-770
20. Filipek S., Krzysko K.A., Fotiadis D., Liang Y., Saperstein D.A., Engel A., et al. A concept for G protein activation by G protein-coupled receptor dimers: the transducin/rhodopsin interface. Photochemical and Photobiological Sciences 3 6 (2004) 628-638
21. Flanagan C.A., Zhou W., Chi L., Yuen T., Rodic V., Robertson D., et al. The functional microdomain in transmembrane helices 2 and 7 regulates expression, activation, and coupling pathways of the gonadotropin-releasing hormone receptor. The Journal of Biological Chemistry 274 41 (1999) 28880-28886
22. Floyd D.H., Geva A., Bruinsma S.P., Overton M.C., Blumer K.J., and Baranski T.J. C5a receptor oligomerization. II. Fluorescence resonance energy transfer studies of a human G protein-coupled receptor expressed in yeast. The Journal of Biological Chemistry 278 37 (2003) 35354-35361
23. Fotiadis D., Jastrzebska B., Philippsen A., Muller D.J., Palczewski K., and Engel A. Structure of the rhodopsin dimer: a working model for G-protein-coupled receptors. Current Opinion in Structural Biology 16 2 (2006) 252-259
24. Fotiadis D., Liang Y., Filipek S., Saperstein D.A., Engel A., and Palczewski K. Atomic-force microscopy: rhodopsin dimers in native disc membranes. Nature 421 6919 (2003) 127-128
25. Fotiadis D., Liang Y., Filipek S., Saperstein D.A., Engel A., and Palczewski K. The G protein-coupled receptor rhodopsin in the native membrane. FEBS Letters 564 3 (2004) 281-288
26. Gerard N.P., and Gerard C. The chemotactic receptor for human C5a anaphylatoxin. Nature 349 6310 (1991) 614-617
27. Gerber B.O., Meng E.C., Dotsch V., Baranski T.J., and Bourne H.R. An activation switch in the ligand binding pocket of the C5a receptor. The Journal of Biological Chemistry 276 5 (2001) 3394-3400
28. Geva A., Lassere T.B., Lichtarge O., Pollitt S.K., and Baranski T.J. Genetic mapping of the human C5a receptor. Identification of transmembrane amino acids critical for receptor function. The Journal of Biological Chemistry 275 45 (2000) 35393-35401
29. Govardhan C.P., and Oprian D.D. Active site-directed inactivation of constitutively active mutants of rhodopsin. The Journal of Biological Chemistry 269 9 (1994) 6524-6527
30. Grossfield A., Feller S.E., and Pitman M.C. Contribution of ω-3 fatty acids to the thermodynamics of membrane protein solvation. Journal of Physical Chemistry B, Condensed Matter, Materials, Surfaces, Interfaces and Biophysical 110 18 (2006) 8907-8909
31. Gross A.K., Rao V.R., and Oprian D.D. Characterization of rhodopsin congenital night blindness mutant T94I. Biochemistry 42 7 (2003) 2009-2015
32. Gross A.K., Xie G., and Oprian D.D. Slow binding of retinal to rhodopsin mutants G90D and T94D. Biochemistry 42 7 (2003) 2002-2008
33. Hamm H.E. How activated receptors couple to G proteins. Proceedings of the National Academy of Sciences of the United States of America 98 9 (2001) 4819-4821
34. Hansen J.L., Theilade J., Haunso S., and Sheikh S.P. Oligomerization of wild type and nonfunctional mutant angiotensin II type I receptors inhibits Gαq protein signaling but not ERK activation. The Journal of Biological Chemistry 279 23 (2004) 24108-24115
35. Hofmann, K.P. (2006). 10th Annual Vision Research Conference: Rhodopsin-Advances and Perspecitves. Fort Lauderdale, Florida.
36. Huang S.H., Pittler S.J., Huang X., Oliveira L., Berson E.L., and Dryja T.P. Autosomal recessive retinitis pigmentosa caused by mutations in the α subunit of rod cGMP phosphodiesterase. Nature Genetics 11 4 (1995) 468-471
37. Hubbell W.L., Altenbach C., Hubbell C.M., and Khorana H.G. Rhodopsin structure, dynamics, and activation: a perspective from crystallography, site-directed spin labeling, sulfhydryl reactivity, and disulfide cross-linking. Advances in Protein Chemistry 63 (2003) 243-290
38. Jastrzebska B., Maeda T., Zhu L., Fotiadis D., Filipek S., Engel A., et al. Functional characterization of rhodopsin monomers and dimers in detergents. The Journal of Biological Chemistry 279 52 (2004) 54663-54675
39. Jin S., Cornwall M.C., and Oprian D.D. Opsin activation as a cause of congenital night blindness. Nature Neuroscience 6 7 (2003) 731-735
40. Kaushal S., and Khorana H.G. Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa. Biochemistry 33 20 (1994) 6121-6128
41. Keen T.J., Inglehearn C.F., Lester D.H., Bashir R., Jay M., Bird A.C., et al. Autosomal dominant retinitis pigmentosa: four new mutations in rhodopsin, one of them in the retinal attachment site. Genomics 11 1 (1991) 199-205
42. Klco J.M., Nikiforovich G.V., and Baranski T.J. Genetic analysis of the first and third extracellular loops of the C5a receptor reveals an essential WXFG motif in the first loop. The Journal of Biological Chemistry 281 17 (2006) 12010-12019
43. Klco J.M., Wiegand C.B., Narzinski K., and Baranski T.J. Essential role for the second extracellular loop in C5a receptor activation. Natural Structural and Molecular Biology 12 4 (2005) 320-326
44. Kohl J. Anaphylatoxins and infectious and non-infectious inflammatory diseases. Molecular Immunology 38 2-3 (2001) 175-187
45. Lem J., and Fain G.L. Constitutive opsin signaling: night blindness or retinal degeneration?. Trends in Molecular Medicine 10 4 (2004) 150-157
46. Lisman J., and Fain G. Support for the equivalent light hypothesis for RP. Nature Medicine 1 12 (1995) 1254-1255
47. Li J., Edwards P.C., Burghammer M., Villa C., and Schertler G.F. Structure of bovine rhodopsin in a trigonal crystal form. Journal of Molecular Biology 343 5 (2004) 1409-1438
48. Luttrell L.M., and Lefkowitz R.J. The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. Journal of Cell Science 115 Pt 3 (2002) 455-465
49. McLaughlin M.E., Sandberg M.A., Berson E.L., and Dryja T.P. Recessive mutations in the gene encoding the beta-subunit of rod phosphodiesterase in patients with retinitis pigmentosa. Nature Genetics 4 2 (1993) 130-134
50. Melia T.J.J., Cowan C.W., Angleson J.K., and Wensel T.G. A comparison of the efficiency of G protein activation by ligand-free and light-activated forms of rhodopsin. Biophysical Journal 73 6 (1997) 3182-3191
51. Mendes H.F., van der Spuy J., Chapple J.P., and Cheetham M.E. Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy. Trends in Molecular Medicine 11 4 (2005) 177-185
52. Meng E.C., and Bourne H.R. Receptor activation: what does the rhodopsin structure tell us?. Trends in Pharmacological Sciences 22 11 (2001) 587-593
53. Mirzadegan T., Benko G., Filipek S., and Palczewski K. Sequence analyses of G-protein-coupled receptors: similarities to rhodopsin. Biochemistry 42 10 (2003) 2759-2767
54. Nakamachi Y., Nakamura M., Fujii S., Yamamoto M., and Okubo K. Oguchi disease with sectoral retinitis pigmentosa harboring adenine deletion at position 1147 in the arrestin gene. American Journal of Ophthalmology 125 2 (1998) 249-251
55. Nakazawa M., Wada Y., and Tamai M. Arrestin gene mutations in autosomal recessive retinitis pigmentosa. Archives of Ophthalmology 116 4 (1998) 498-501
56. Nemethy G., Pottle M., and Scheraga H. Energy parameters in polypeptides. 9. Updating of geometrical parameters, nonbonded interactions, and hydrogen bond interactions for the naturally occurring amino acids. Journal of Physical Chemistry 87 (1983) 1883-1887
57. Neves S.R., Ram P.T., and Iyengar R. G protein pathways. Science 296 5573 (2002) 1636-1639
58. Nikiforovich G.V., Galaktionov S., Balodis J., and Marshall G.R. Novel approach to computer modeling of seven-helical transmembrane proteins: current progress in the test case of bacteriorhodopsin. Acta Biochimica Polonica 48 1 (2001) 53-64
59. Nikiforovich G.V., Hruby V.J., Prakash O., and Gehrig C.A. Topographical requirements for delta-selective opioid peptides. Biopolymers 31 8 (1991) 941-955
60. Nikiforovich G.V., and Marshall G.R. Three-dimensional model for meta-II rhodopsin, an activated G-protein-coupled receptor. Biochemistry 42 30 (2003) 9110-9120
61. Nikiforovich G.V., and Marshall G.R. 3D modeling of the activated states of constitutively active mutants of rhodopsin. Biochemical and Biophysical Research Communications (2006)
62. Nikiforovich, G.V., Sen, S., & Baranski, T.J. (2006) Rational design of constitutively active mutants of the human C5a receptor. 29th European Peptide Symposium, Gdansk, Poland.
63. Okada T., Fujiyoshi Y., Silow M., Navarro J., Landau E.M., and Shichida Y. Functional role of internal water molecules in rhodopsin revealed by X-ray crystallography. Proceedings of the National Academy Sciences of the United States of America 99 9 (2002) 5982-5987
64. Okada T., Sugihara M., Bondar A.N., Elstner M., Entel P., and Buss V. The retinal conformation and its environment in rhodopsin in light of a new 2.2 Å crystal structure. Journal of Molecular Biology 342 2 (2004) 571-583
65. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., et al. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 289 5480 (2000) 739-745
66. Perlman J.H., Colson A.O., Wang W., Bence K., Osman R., and Gershengorn M.C. Interactions between conserved residues in transmembrane helices 1, 2, and 7 of the thyrotropin-releasing hormone receptor. The Journal of Biological Chemistry 272 18 (1997) 11937-11942
67. Phelan J.K., and Bok D. A brief review of retinitis pigmentosa and the identified retinitis pigmentosa genes. Molecular Vision 6 (2000) 116-124
68. Rajan R.S., and Kopito R.R. Suppression of wild-type rhodopsin maturation by mutants linked to autosomal dominant retinitis pigmentosa. The Journal of Biological Chemistry 280 2 (2005) 1284-1291
69. Ramon E., del Valle L.J., and Garriga P. Unusual thermal and conformational properties of the rhodopsin congenital night blindness mutant Thr-94 → Ile. The Journal of Biological Chemistry 278 8 (2003) 6427-6432
70. Rao V.R., Cohen G.B., and Oprian D.D. Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness. Nature 367 6464 (1994) 639-642
71. Rao V.R., and Oprian D.D. Activating mutations of rhodopsin and other G protein-coupled receptors. Annual Review of Biophysics and Biomolecular Structure 25 (1996) 287-314
72. Revankar C.M., Cimino D.F., Sklar L.A., Arterburn J.B., and Prossnitz E.R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307 5715 (2005) 1625-1630
73. Robinson P.R., Cohen G.B., Zhukovsky E.A., and Oprian D.D. Constitutively active mutants of rhodopsin. Neuron 9 4 (1992) 719-725
74. Sealfon S.C., Chi L., Ebersole B.J., Rodic V., Zhang D., Ballesteros J.A., et al. Related contribution of specific helix 2 and 7 residues to conformational activation of the serotonin 5-HT2A receptor. The Journal of Biological Chemistry 270 28 (1995) 16683-16688
75. Sheikh S.P., Zvyaga T.A., Lichtarge O., Sakmar T.P., and Bourne H.R. Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F. Nature 383 6598 (1996) 347-350
76. Stojanovic A., Hwang I., Khorana H.G., and Hwa J. Retinitis pigmentosa rhodopsin mutations L125R and A164V perturb critical interhelical interactions: new insights through compensatory mutations and crystal structure analysis. The Journal of Biological Chemistry 278 40 (2003) 39020-39028
77. Sung C.H., Davenport C.M., and Nathans J. Rhodopsin mutations responsible for autosomal dominant retinitis pigmentosa. Clustering of functional classes along the polypeptide chain. The Journal of Biological Chemistry 268 35 (1993) 26645-26649
78. Sung C.H., Schneider B.G., Agarwal N., Papermaster D.S., and Nathans J. Functional heterogeneity of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa. Proceedings of the National Academy of Sciences of the United States of America 88 19 (1991) 8840-8844
79. Surya A., Foster K.W., and Knox B.E. Transducin activation by the bovine opsin apoprotein. The Journal of Biological Chemistry 270 10 (1995) 5024-5031
80. Takeda S., Kadowaki S., Haga T., Takaesu H., and Mitaku S. Identification of G protein-coupled receptor genes from the human genome sequence. FEBS Letters 520 1-3 (2002) 97-101
81. Teller D.C., Okada T., Behnke C.A., Palczewski K., and Stenkamp R.E. Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). Biochemistry 40 26 (2001) 7761-7772
82. Tsao P., Cao T., and von Zastrow M. Role of endocytosis in mediating downregulation of G-protein-coupled receptors. Trends in Pharmacological Sciences 22 2 (2001) 91-96
83. In: Wess J. (Ed). Structure-function analysis of G protein-coupled receptors. Receptor biochemistry and methodology (1999), Wiley-Liss, New York
84. Whistler J.L., Gerber B.O., Meng E.C., Baranski T.J., von Zastrow M., and Bourne H.R. Constitutive activation and endocytosis of the complement factor 5a receptor: evidence for multiple activated conformations of a G protein-coupled receptor. Traffic 3 12 (2002) 866-877
85. Woodruff M.L., Wang Z., Chung H.Y., Redmond T.M., Fain G.L., and Lem J. Spontaneous activity of opsin apoprotein is a cause of Leber congenital amaurosis. Nature Genetics 35 2 (2003) 158-164
86. Zhou W., Flanagan C., Ballesteros J.A., Konvicka K., Davidson J.S., Weinstein H., et al. A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor. Molecular Pharmacology 45 2 (1994) 165-170
87. Zhu L., Imanishi Y., Filipek S., Alekssev A., Jastrzebska B., Sun W., et al. Autosomal recessive retinitis pigmentosa and E150K mutation in the opsin gene. The Journal of Biological Chemistry 281 31 (2006) 22289-22298